I

Inovio Pharmaceuticals
D

INO

2.23000
USD
0.02
(0.91%)
مغلق
حجم التداول
45,004
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
80,502,980
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AMRN
    -0.00130
    (-0.22%)
    0.58930 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    A
    AXSM
    8.550
    (6.62%)
    137.720 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    I
    INO
    0.02000
    (0.91%)
    2.23000 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    V
    VCEL
    -2.230
    (-4.11%)
    52.060 USD
    V
    VKTX
    2.480
    (7.85%)
    34.090 USD
    المزيد
الأخبار
المقالات

العنوان: Inovio Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.